|
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
RECRUITINGN/ASponsored by Duke University
Actively Recruiting
PhaseN/A
SponsorDuke University
Started2025-07-14
Est. completion2029-06-30
Eligibility
Age18 Years – 39 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06371768
Summary
The purpose of this study is to determine the effectiveness of a digital health program called AYA STEPS, which is designed to help adolescent and young adult (AYA) cancer survivors manage symptoms and engage in recommended follow-up care.
Eligibility
Age: 18 Years – 39 YearsHealthy volunteers accepted
Inclusion Criteria: * Diagnosed with one of the following cancers: 1) stage I-III breast cancer; 2) stage I-III colorectal cancer; 3) stage I-III sarcoma; 4) stage I-III Hodgkin or non-Hodgkin lymphoma; or 5) stage I-II testicular cancer * treated with curative intent and off therapy (with the exception of endocrine/hormonal therapy or oral targeted therapies used to prevent disease recurrence or progression) for the last three months * 1 to 5 years post-diagnosis * Able to speak and read English * Able to give informed consent Exclusion Criteria: * moderate or severe cognitive impairment * severe untreated mental illness (e.g., schizophrenia, substance use disorder) that would interfere with providing meaningful consent/study participation
Conditions6
Breast CancerCancerColorectal CancerLymphomaSarcomaTesticular Cancer
Locations1 site
Duke Cancer Institute
Durham, North Carolina, 27705
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorDuke University
Started2025-07-14
Est. completion2029-06-30
Eligibility
Age18 Years – 39 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06371768